oxeladin
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2020 (NCT05022108)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
STAT3 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CCN(CC)CCOCCOC(=O)C(CC)(CC)c1ccccc1- Mol. weight
- 335.49 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2104360 ↗
- ChEMBLCHEMBL1561544 ↗
- ChEMBLCHEMBL1500276 ↗
Also known as
- oxeladin
- oxeladin
- oxeladin
- oxeladin
- oxeladin
- oxeladin
- oxeladin
- oxeladin citrate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04940520 | Phase 1 | Jun 1, 2020 | Universidade do Vale do Sapucai |
| NCT05022108 | Phase 1 | Apr 1, 2020 | Universidade do Vale do Sapucai |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Universidade do Vale do Sapucai | Academic/Hospital | 2 | 2 | 1 | 2020 |
1 organizations
Page 1 / 1